Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Power, Andrew Westle, G. Dowsett, J. Lucke, J. Tucker, J. Sugarman, S. Lewin, S. Hill, Graham Brown, J. Wallace, J. Richmond (2018)
Perceptions of HIV cure research among people living with HIV in AustraliaPLoS ONE, 13
N. Eyal, Lisa Holtzman, S. Deeks (2018)
Ethical issues in HIV remission trialsCurrent Opinion in HIV and AIDS, 13
A. Kratka, P. Ubel, Karen Scherr, B. Murray, N. Eyal, Christine Kirby, Madelaine Katz, Lisa Holtzman, K. Pollak, Kenneth Freedburg, J. Blumenthal-Barby (2019)
HIV Cure Research: Risks Patients Expressed Willingness to Accept.Ethics & human research, 41 6
K. Dubé, J. Auerbach, M. Stirratt, P. Gaist (2019)
Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure ResearchJournal of the International AIDS Society, 22
L. Dee, C. Boone, D. Palm, Danielle Campbell, K. Dubé (2019)
Secondary HIV Infection and Mitigation in Cure-Related HIV Trials During Analytical Treatment Interruptions.The Journal of infectious diseases, 220 7
B. Julg, L. Dee, J. Ananworanich, D. Barouch, K. Bar, M. Caskey, D. Colby, Liza Dawson, K. Dong, K. Dubé, J. Eron, J. Frater, R. Gandhi, R. Geleziunas, P. Goulder, G. Hanna, R. Jefferys, Rowena Johnston, D. Kuritzkes, Jonathan Li, Udom Likhitwonnawut, J. Lunzen, J. Martinez-Picado, V. Miller, L. Montaner, D. Nixon, D. Palm, G. Pantaleo, H. Peay, D. Persaud, J. Salzwedel, K. Salzwedel, T. Schacker, Virginia Sheikh, O. Søgaard, S Spudich, K. Stephenson, J. Sugarman, Jeff Taylor, P. Tebas, C. Tiemessen, R. Tressler, C. Weiss, Lu Zheng, M. Robb, N. Michael, J. Mellors, S. Deeks, B. Walker (2019)
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.The lancet. HIV, 6 4
K. Moodley, C. Staunton, T. Rossouw, M. Roubaix, Z. Duby, D. Skinner (2019)
The psychology of “cure” - unique challenges to consent processes in HIV cure research in South AfricaBMC Medical Ethics, 20
Provides a broad set of recommendations for the use of ATIs developed with multiple stakeholders taking into account earlier discussions related to the issue
K. Dubé, S. Gianella, S. Concha-Garcia, S. Little, Andy Kaytes, Jeff Taylor, Kushagra Mathur, S. Javadi, Anshula Nathan, H. Patel, Stuart Luter, Sean Philpott-Jones, B. Brown, Davey Smith (2018)
Ethical considerations for HIV cure-related research at the end of lifeBMC Medical Ethics, 19
An interview study that identified unique perspectives on ATIs among participants
A multimethod study that makes recommendations to overcome barriers to consent for HIV cure research
S. Deeks, S. Lewin, A. Ross, J. Ananworanich, M. Benkirane, P. Cannon, N. Chomont, D. Douek, J. Lifson, Y. Lo, D. Kuritzkes, D. Margolis, J. Mellors, D. Persaud, J. Tucker, F. Barré-Sinoussi, G. Alter, J. Auerbach, B. Autran, D. Barouch, G. Behrens, M. Cavazzana, Zhiwei Chen, É. Cohen, G. Corbelli, S. Eholie, N. Eyal, S. Fidler, L. Garcia, Cynthia Grossman, G. Henderson, T. Henrich, R. Jefferys, H. Kiem, J. McCune, K. Moodley, P. Newman, M. Nijhuis, M. Nsubuga, M. Ott, S. Palmer, D. Richman, A. Sáez-Cirión, M. Sharp, J. Siliciano, G. Silvestri, J. Singh, B. Spire, Jeffrey Taylor, M. Tolstrup, S. Valente, J. Lunzen, R. Walensky, I. Wilson, J. Zack (2016)
International AIDS Society global scientific strategy: towards an HIV cure 2016Nature Medicine, 22
P. Revill, F. Chisari, Joan Block, M. Dandri, A. Gehring, Haitao Guo, Jianming Hu, A. Kramvis, P. Lampertico, H. Janssen, M. Levrero, Wenhui Li, T. Liang, S. Lim, F. Lu, M. Penicaud, J. Tavis, R. Thimme, F. Zoulim, P. Arbuthnot, A. Boonstra, K.‐M. Chang, Per-Jei Chen, D. Glebe, L. Guidotti, J. Fellay, C. Ferrari, L. Jansen, Daryl Lau, Anna Lok, M. Maini, W. Mason, G. Matthews, D. Paraskevis, J. Petersen, B. Rehermann, E. Shin, A. Thompson, F. Bömmel, Fu-sheng Wang, Koichi Watashi, Hung‐Chih Yang, Zhenghong Yuan, Man-Fung Yuen, Tim Block, V. Miller, U. Protzer, C. Bréchot, S. Locarnini, M. Peters, R. Schinazi (2019)
A global scientific strategy to cure hepatitis B.The lancet. Gastroenterology & hepatology, 4 7
Luke Newton, Raúl Necochea, D. Palm, Jeff Taylor, Liz Barr, H. Patel, Anshula Nathan, J. Gerrard, L. Sylla, B. Brown, K. Dubé (2019)
Revisiting the ‘sterilising cure’ terminology: a call for more patient-centred perspectives on HIV cure-related researchJournal of Virus Eradication, 5
K. Dubé, Stuart Luter, Breanne Lesnar, Luke Newton, J. Galea, B. Brown, S. Gianella (2018)
Use of ‘eradication’ in HIV cure-related research: a public health debateBMC Public Health, 18
G. Henderson, H. Peay, E. Kroon, R. Cadigan, K. Meagher, T. Jupimai, A. Gilbertson, J. Fisher, N. Ormsby, N. Chomchey, N. Phanuphak, J. Ananworanich, S. Rennie (2017)
Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessmentJournal of Medical Ethics, 44
S. Garner, S. Rennie, J. Ananworanich, K. Dubé, D. Margolis, J. Sugarman, R. Tressler, A. Gilbertson, Liza Dawson (2017)
Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerationsJournal of Virus Eradication, 3
J. Sugarman, P. Revill, F. Zoulim, Y. Yazdanpanah, H. Janssen, S. Lim, S. Lewin (2016)
Ethics and hepatitis B cure researchGut, 66
B. Murray, A. Kratka, Karen Scherr, N. Eyal, J. Blumenthal-Barby, K. Freedberg, D. Kuritzkes, J. Hammitt, R. Edifor, Madelaine Katz, K. Pollak, B. Zikmund‐Fisher, S. Halpern, M. Barks, P. Ubel (2019)
What risk of death would people take to be cured of HIV and why? A survey of people living with HIVJournal of Virus Eradication, 5
K. Dubé, L. Sylla, L. Dee, Jeff Taylor, D. Evans, Carl Bruton, Adam Gilberston, Lisa Gralinski, B. Brown, A. Skinner, B. Weiner, S. Greene, A. Corneli, A. Adimora, J. Tucker, S. Rennie (2017)
Research on HIV cure: Mapping the ethics landscapePLoS Medicine, 14
K. Dubé, Liz Barr, D. Palm, B. Brown, Jeff Taylor (2019)
Putting participants at the centre of HIV cure research.The lancet. HIV, 6 3
Liza Dawson (2019)
Human Immunodeficiency Virus Transmission Risk in Analytical Treatment Interruption Studies: Relational Factors and Moral Responsibility.The Journal of infectious diseases, 220 Supplement_1
B. Lo, C. Grady (2013)
Ethical considerations in HIV cure research: points to considerCurrent Opinion in HIV and AIDS, 8
Regina Brown, S. Deeks, N. Eyal (2018)
Maximising the global health impact of future HIV cure-related interventions through advance planningJournal of Virus Eradication, 4
N. Eyal (2016)
The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introductionJournal of Medical Ethics, 43
Steven Chu, S. Deeks, B. Autran, B. Berkhout, M. Benkirane, S. Cairns, N. Chomont, T. Chun, M. Churchill, M. Mascio, C. Katlama, A. Lafeuillade, A. Landay, M. Lederman, S. Lewin, F. Maldarelli, D. Margolis, M. Markowitz, J. Martinez-Picado, J. Mullins, J. Mellors, S. Moreno, U. O’Doherty, S. Palmer, M. Penicaud, M. Peterlin, G. Poli, J. Routy, C. Rouzioux, G. Silvestri, M. Stevenson, A. Telenti, C. Lint, E. Verdin, A. Woolfrey, J. Zaia, F. Barré-Sinoussi (2012)
Towards an HIV cure: a global scientific strategyNature Reviews Immunology, 12
Provides an overview of a symposium of related articles that are not reviewed here, but may be of interest
N. Eyal, S. Deeks (2019)
Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A SymposiumThe Journal of Infectious Diseases, 220
N. Eyal, D. Kuritzkes (2013)
Challenges in clinical trial design for HIV-1 cure researchThe Lancet, 382
J. Sugarman (2013)
HIV Cure Research: Expanding the Ethical ConsiderationsAnnals of Internal Medicine, 159
Downloaded from http://journals.lww.com/co-hivandaids by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9l2nY+zyylnl33NGMK6MRsx on 10/02/2020 REVIEW URRENT PINION a,b,c Jeremy Sugarman Purpose of review Achieving a cure for HIV or hepatitis B virus (HBV) is expected to have a range of salutary effects including eliminating the need for continued treatments, minimizing risk to sexual and injecting partners, reducing prevalence, and decreasing stigma. Nevertheless, conducting research to achieve such laudable goals is necessarily associated with a broad set of ethical challenges. This review aims at describing key findings from selected peer-reviewed literature published in the last 2 years (2018–2019) that enhance understanding of some of these issues. Recent findings A variety of ethical issues in HIV cure research have been informed by recent conceptual and empirical scholarship. These include: analytical treatment interruptions; attitudes towards participation; responsibilities to nonparticipants; consent and terminology; and selected other issues. Summary Understanding of the ethical issues in HIV cure research has been enhanced by sustained normative and empirical scholarship with a range of stakeholders. This work has crucial implications for HBV cure research, but there is also a pressing need for directed work on HBV cure research. In both HIV and HBV cure research, such scholarship promises to help ensure that critically important
Current Opinion in HIV & AIDS – Wolters Kluwer Health
Published: May 1, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.